1. Home
  2. YMT vs LPCN Comparison

YMT vs LPCN Comparison

Compare YMT & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YMT

Yimutian Inc. American Depositary Shares

N/A

Current Price

$0.87

Market Cap

19.4M

Sector

Technology

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$2.08

Market Cap

19.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YMT
LPCN
Founded
2011
1997
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4M
19.1M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
YMT
LPCN
Price
$0.87
$2.08
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
319.3K
86.6K
Earning Date
06-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
N/A
N/A
Revenue
N/A
$1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$92.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$1.81
52 Week High
$2.85
$12.37

Technical Indicators

Market Signals
Indicator
YMT
LPCN
Relative Strength Index (RSI) 51.33 29.79
Support Level $0.14 $1.81
Resistance Level $1.90 $2.50
Average True Range (ATR) 0.27 0.11
MACD -0.04 0.06
Stochastic Oscillator 3.51 7.58

Price Performance

Historical Comparison
YMT
LPCN

About YMT Yimutian Inc. American Depositary Shares

Yimutian Inc is the largest agricultural B2B platform in mainland China. It provide a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching, matching, to transaction facilitation and settlement. The company pride itself as the go-to platform for merchants by leveraging its inventive technology and industry know-how. Its platform had over 38 million merchants. It has also established approximately 12 offline stores in mainland China to trade agricultural products at cultivation and production sites with sellers and buyers.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: